A carregar...

Clinical pharmacology of moxalactam in patients with malignant disease.

Pharmacological studies of moxalactam were conducted with 37 cancer patients. Intramuscular administration of 500 mg of moxalactam to 10 patients produced a mean peak serum concentration of 12.4 micrograms/ml. The serum terminal-phase half-life was 3.9 h. Intravenous administration of 500 mg of moxa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Estey, E H, Weaver, S S, Ho, D H, Bodey, G P
Formato: Artigo
Idioma:Inglês
Publicado em: 1981
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC181493/
https://ncbi.nlm.nih.gov/pubmed/6454389
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!